NanoMedSyn

The days of partnership R&D in health.  

Dive into Antibody next generation with NanoMedSyn technology.

NanoMedSyn develops an application of its vectors on therapeutic antibodies and probes that the addition of AMFA (=M6Pn) does not alter antigen recognition or FcRn recycling. The article is published by Journal of Controlled Release. J Control Release 2023, 358:465-475.

NanoMedSyn will participate to the International Symposium on Inorganic  and Environmental Materials ISIEM2023 in Montpellier, France. The symposium will focus on the newest research and technologies on inorganic materials : Nanomaterials, Biomaterials, Functional Materials…

Join us at Paris Saclay B2B on June, the 1st and 2nd.

We will be present at BIO-Europe Spring for one-to-one meeting.

The 3rd Immune-Oncology World Congress Immuno-Oncology2022 will focus on the latest developments and findings in immuno-oncology therapy as well as targeted therapy. The Congress will examine treatments available on the market as well as treatments still in the development stage. A…

Immunology, looking to the future of medical sciences. The Thematic Meeting: « Immunology, looking to the future of medical sciences » is a major event for the immunology sector in the south of France.

Day of the cluster : Biotherapy Innovation Occitanie October 13, 2022 in Montpellier  

NanoMedSyn is co-organiser of  the 2nd Symposium on delivery and target for pediatric tumors, on 23-24th June in Switzerland (Schwarzsee). Our collaborative work and of the company have been presented.